IP Library Granted Patent US 7,082,326
Granted Patent B2
US 7,082,326 · App. 10/256,397 · Granted Jul 25, 2006

Method of magnetic resonance imaging

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,082,326
App. No.
10/256,397
Granted
Jul 25, 2006
Kind
B2
Abstract

A method of magnetic resonance (MR) imaging of blood perfusion in vascularized organs of interest, e.g. the myocardium, the kidneys, the brain, the liver wherein a contrast agent composition comprising a particulate superparamagnetic metal oxide is administered.

Claims (7)

1. A method of first pass, contrast enhanced organ perfusion magnetic resonance imaging of a human or vascularized animal subject, comprising administering a MR contrast agent composition comprising a particulate superparamagnetic metal oxide into the vasculature of said subject and generating magnetic resonance images of slices through a vascularized organ of said subject during the passage of said agent through the vasculature of said organ, wherein pre-saturation slabs in the phase encoding direction and a T 2 -weighted single shot Turbo (fast) spin-echo sequence are used to generate said images.

2. The method as claimed in claim 1 wherein said vascularized organ is the myocardium, the kidneys, the brain or the liver.

3. The method as claimed in claim 1 wherein said vascularized organ is the myocardium.

4. The method according to claim 1 wherein said superparamagnetic metal oxide is a superparamagnetic iron oxide.

5. The method as claimed in claim 4 wherein said superparamagnetic iron oxide is an ultra small superparamagnetic iron oxide (USPIO).

6. The method as claimed in claim 5 wherein said ultra small superparamagnetic iron oxide (USIPO) having on its surface an optionally modified carbohydrate or polysaccharide or derivative thereof.

7. The method as claimed in claim 1 wherein said MR contrast agent composition is administered by bolus injection over a period of less than 3 minutes.

Assignments (3)
CHANGE OF NAME Recorded Aug 2, 2006
From: AMERSHAM HEALTH AS; NYCOMED IMAGING AS
To: GE HEALTHCARE AS
Reel/Frame 018039/0537 →
CHANGE OF NAME Recorded Mar 23, 2004
From: NYCOMED IMAGING AS
To: AMERHSAM HEALTH AS
Reel/Frame 014453/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2003
From: JOHANSSON, LARS
To: NYCOMED IMAGING AS
Reel/Frame 013882/0902 →